WA
ARLZ

WFG Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

WFG Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3K Buy
+2,500
New +$3.61K ﹤0.01% 1394

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

WFG Advisors's ARLZ Position: Q2 2017 in Review

WFG Advisors opened a new position in Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2017: 2,500 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1394 among its holdings.

72 funds tracked by Wall St. Rank hold ARLZ as of Q2 2017.

  • WFG Advisors held 2,500 shares of Aralez Pharmaceuticals Inc. worth $3K as of Q2 2017.
  • Aralez Pharmaceuticals Inc. was a new WFG Advisors position in Q2 2017.
  • Aralez Pharmaceuticals Inc. made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1394 holding.
  • 72 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.